Clinical effect of alfacalcidol in children with Henoch-Schönlein purpura: a prospective randomized controlled trial.
10.7499/j.issn.1008-8830.2105136
- Author:
Qiang FU
1
;
Ming-Fang SHI
1
;
Ying CHEN
1
Author Information
1. Department of Pediatrics, First People's Hospital of Yibin, Yibin, Sichuan 644000, China.
- Publication Type:Randomized Controlled Trial
- Keywords:
Alfacalcidol;
Child;
Henoch-Schönlein purpura;
Immunity;
Inflammatory factor
- MeSH:
Child;
Humans;
Hydroxycholecalciferols;
Interleukin-6;
Prospective Studies;
Purpura, Schoenlein-Henoch/drug therapy*
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(8):797-801
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:To study the effects of alfacalcidol on serum 25-(OH)D
METHODS:A total of 200 children with HSP were prospectively enrolled from June 2018 to June 2020. According to the random number table method, they were divided into an observation group and a control group (
RESULTS:After treatment, the observation group showed a significantly higher serum 25-(OH)D
CONCLUSIONS:Alfacalcidol can increase the serum 25-(OH)D
